Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
74.71
-0.17 (-0.23%)
At close: Feb 10, 2026, 4:00 PM EST
74.88
+0.17 (0.23%)
After-hours: Feb 10, 2026, 4:10 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $740.63 million as of February 10, 2026. Its market cap has increased by 243.36% in one year.
Market Cap
740.63M
Enterprise Value
679.64M
1-Year Change
243.36%
Ranking
Category
Stock Price
$74.71
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $740.63M, an increase of 1,672.56%. That is a compound annual growth rate of 77.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 740.63M | 18.09% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Janux Therapeutics | 786.13M |
| MiMedx Group | 762.73M |
| KalVista Pharmaceuticals | 753.14M |
| Nektar Therapeutics | 748.77M |
| MapLight Therapeutics | 741.03M |
| Arbutus Biopharma | 738.52M |
| Cullinan Therapeutics | 722.50M |
| Gyre Therapeutics | 716.22M |